Bausch + Lomb said it authorized management and advisers to explore a potential sale of the eye health company after shares dropped over reports of faltering deal talks with a group of private equity firms. The company said a sale was “one of several options being explored to complete a full separation from Bausch Health Companies Inc.,” in a statement on Thursday.
Source: FlipItMoneyAd
Ad